JAMIE MCGUIRE: Open Payments
NPI 1598179863 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61,119 in 205 payments from 19 companies in 2025. Trend: 2023 $419 · 2024 $24,421 · 2025 $61,119
Speaker / faculty: $51,619Travel & lodging: $5,057Food & beverage: $4,407Education: $36
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 82 | $58,914 |
| Otsuka America Pharmaceutical, Inc. | 21 | $256 |
| Lundbeck LLC | 12 | $228 |
| Alkermes, Inc. | 14 | $208 |
| Lilly USA, LLC | 6 | $207 |
| Vanda Pharmaceuticals Inc. | 10 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $189 |
| Axsome Therapeutics, Inc. | 2 | $144 |
| Neurocrine BioSciences, Inc. | 11 | $139 |
| Teva Pharmaceuticals USA, Inc. | 6 | $124 |
Products named: Wegovy, REXULTI, ZEPBOUND, CAPLYTA, ARISTADA, HETLIOZ, INGREZZA, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
